Does Price T Rowe Associates own SAGE stock?

As of its Q2 2025 13F, Price T Rowe Associates held 43,762 shares of SAGE (Sage Therapeutics), worth $400,000.

How many shares of SAGE does Price T Rowe Associates own?

As of its Q2 2025 13F, Price T Rowe Associates held 43,762 shares of SAGE (Sage Therapeutics).

As of its Q2 2025 13F, Price T Rowe Associates' SAGE position was worth $400,000.

Price T Rowe Associates already held SAGE in its Q3 2019 13F, the earliest on record, and listed it in 24 quarterly 13F filings.

Position history for PRICE T ROWE ASSOCIATES INC /MD/'s holdings in SAGE THERAPEUTICS INC

Final Value

Final Shares

Total Value Change

-$1B

Total Shares Change

-7.5M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2025-Q2	Increased	43,762	+11.7%	$400,000	0.0%	—	18
2025-Q1	Decreased	39,167	-90.5%	$312,000	0.0%	—	0
2024-Q4	Decreased	414,221	-8.1%	$2.3M	0.0%	—	0
2024-Q3	Decreased	450,637	-12.1%	$3.3M	0.0%	—	0
2024-Q2	Decreased	512,837	-36.8%	$5.6M	0.0%	—	0
2024-Q1	Increased	811,934	+69.8%	$15.2M	0.0%	—	42
2023-Q4	Decreased	478,129	-17.9%	$10.4M	0.0%	—	0
2023-Q3	Decreased	582,272	-46.1%	$12M	0.0%	—	0
2023-Q2	Decreased	1.1M	-43.4%	$50.8M	0.0%	—	0
2023-Q1	Increased	1.9M	+0.6%	$80.1M	0.0%	—	30
2022-Q4	Decreased	1.9M	-11.4%	$72.4M	0.0%	—	0
2022-Q3	Increased	2.1M	+3.0%	$83.8M	0.0%	—	31
2022-Q2	Decreased	2.1M	-3.8%	$67.1M	0.0%	—	0
2022-Q1	Increased	2.2M	+52.4%	$71.4M	0.0%	—	41
2021-Q4	Increased	1.4M	+0.7%	$60.3M	0.0%	—	30
2021-Q3	Decreased	1.4M	-10.5%	$62.3M	0.0%	—	0
2021-Q2	Decreased	1.6M	-34.7%	$89.3M	0.0%	—	0
2021-Q1	Increased	2.4M	+2.1%	$180.2M	0.0%	—	31
2020-Q4	Decreased	2.4M	-7.9%	$203.9M	0.0%	—	0
2020-Q3	Decreased	2.6M	-9.2%	$156.4M	0.0%	—	0
2020-Q2	Decreased	2.8M	-4.9%	$117.2M	0.0%	—	0
2020-Q1	Decreased	3M	-47.5%	$85.1M	0.0%	—	0
2019-Q4	Decreased	5.6M	-24.3%	$407.8M	0.1%	—	0
2019-Q3	First report	7.5M	-	$1B	0.1%	—	0